| Product NDC: | 0310-0325 |
| Proprietary Name: | MERREM |
| Non Proprietary Name: | Meropenem |
| Active Ingredient(s): | 500 mg/20mL & nbsp; Meropenem |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0310-0325 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050706 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960923 |
| Package NDC: | 0310-0325-20 |
| Package Description: | 10 VIAL in 1 CARTON (0310-0325-20) > 20 mL in 1 VIAL |
| NDC Code | 0310-0325-20 |
| Proprietary Name | MERREM |
| Package Description | 10 VIAL in 1 CARTON (0310-0325-20) > 20 mL in 1 VIAL |
| Product NDC | 0310-0325 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Meropenem |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960923 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | MEROPENEM |
| Strength Number | 500 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] |